What is the address of Dr. B. Strubbe, gastro-enterologie?

The registered office of Dr. B. Strubbe, gastro-enterologie is located at Gustaaf De Smetlaan 8, 9831 Sint-Martens-Latem.

Is Dr. B. Strubbe, gastro-enterologie still active?

Yes. According to the CBE (16 September 2026) Dr. B. Strubbe, gastro-enterologie is active, legal situation “Normale toestand”, started on 20 December 2021.

Is Dr. B. Strubbe, gastro-enterologie registered on Peppol?

Yes, Dr. B. Strubbe, gastro-enterologie is registered on the Peppol network with ID 0208:0778837249.

What is the enterprise number of Dr. B. Strubbe, gastro-enterologie?

The enterprise number of Dr. B. Strubbe, gastro-enterologie is BE0778837249.

When was Dr. B. Strubbe, gastro-enterologie founded?

Dr. B. Strubbe, gastro-enterologie was founded on 20 December 2021.

Who are the directors of Dr. B. Strubbe, gastro-enterologie?

According to the 2025 annual accounts, the directors of Dr. B. Strubbe, gastro-enterologie are: Beatrijs Strubbe.

Is Dr. B. Strubbe, gastro-enterologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 December 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. B. Strubbe, gastro-enterologie make in 2025?

Dr. B. Strubbe, gastro-enterologie posted a profit after taxes of € 224,861 in financial year 2025.

What is the revenue of Dr. B. Strubbe, gastro-enterologie?

As a small company, Dr. B. Strubbe, gastro-enterologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 329,123.

Dr. B. Strubbe, gastro-enterologie (Private Limited)

Dossier Dr. B. Strubbe, gastro-enterologie, printed on 16 September 2026 from databakkes.be/en/0778837249/dr-b-strubbe-gastro-enterologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. B. Strubbe, gastro-enterologie from Sint-Martens-Latem, company number BE0778837249, closed financial year 2025 with a result of € 224,861 after tax. For that financial year Dr. B. Strubbe, gastro-enterologie recorded a gross margin of € 329,123 and equity of € 13,540. Compared with financial year 2024, the result moved from € 224,015 to € 224,861. Profitable, and profit is growing. The buffer shrank hard: equity is 98 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Shrank hard

€ 13,540

▼ 98% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 224,861

Profit after tax over the fiscal year.

Cash in the bank

€ 13,735

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 810,400 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 711

▲ 82% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,050

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 350,566 Gross margin 2022: € 350,566 First fiscal year in the series	€ 231,735 Gross margin 2023: € 231,735 ▼ 34% vs 2022 (€ 350,566) Unfavourable step	€ 328,017 Gross margin 2024: € 328,017 ▲ 42% vs 2023 (€ 231,735) Favourable step	€ 329,123 Gross margin 2025: € 329,123 Unchanged (€ 328,017) Favourable step
Profit after taxes	€ 226,973 Profit after taxes 2022: € 226,973 First fiscal year in the series	€ 148,492 Profit after taxes 2023: € 148,492 ▼ 35% vs 2022 (€ 226,973) Unfavourable step	€ 224,015 Profit after taxes 2024: € 224,015 ▲ 51% vs 2023 (€ 148,492) Favourable step	€ 224,861 Profit after taxes 2025: € 224,861 Unchanged (€ 224,015) Favourable step
Equity	€ 228,573 Equity 2022: € 228,573 First fiscal year in the series	€ 376,065 Equity 2023: € 376,065 ▲ 65% vs 2022 (€ 228,573) Favourable step	€ 599,080 Equity 2024: € 599,080 ▲ 59% vs 2023 (€ 376,065) Favourable step	€ 13,540 Equity 2025: € 13,540 ▼ 98% vs 2024 (€ 599,080) Unfavourable step	▼ 98%
Total debts	€ 128,765 Total debts 2022: € 128,765 First fiscal year in the series	€ 11,033 Total debts 2023: € 11,033 ▼ 91% vs 2022 (€ 128,765) Favourable step	€ 8,444 Total debts 2024: € 8,444 ▼ 23% vs 2023 (€ 11,033) Favourable step	€ 724,156 Total debts 2025: € 724,156 ▲ € 715,712 vs 2024 (€ 8,444) Unfavourable step	▲ € 715,712
Cash	€ 71,704 Cash 2022: € 71,704 First fiscal year in the series	€ 34,193 Cash 2023: € 34,193 ▼ 52% vs 2022 (€ 71,704) Unfavourable step	€ 12,020 Cash 2024: € 12,020 ▼ 65% vs 2023 (€ 34,193) Unfavourable step	€ 13,735 Cash 2025: € 13,735 ▲ 14% vs 2024 (€ 12,020) Favourable step	▲ 14%
Retained profit	€ 225,573 Retained profit 2022: € 225,573 First fiscal year in the series	€ 373,065 Retained profit 2023: € 373,065 ▲ 65% vs 2022 (€ 225,573) Favourable step	€ 596,080 Retained profit 2024: € 596,080 ▲ 60% vs 2023 (€ 373,065) Favourable step	€ 10,540 Retained profit 2025: € 10,540 ▼ 98% vs 2024 (€ 596,080) Unfavourable step	▼ 98%
Dividend	€ 1,400 Dividend 2022: € 1,400 First fiscal year in the series	€ 1,000 Dividend 2023: € 1,000 ▼ 29% vs 2022 (€ 1,400) Unchanged	€ 1,000 Dividend 2024: € 1,000 Unchanged (€ 1,000) Unchanged	€ 810,400 Dividend 2025: € 810,400 ▲ € 809,400 vs 2024 (€ 1,000) Unchanged	▲ € 809,400
Balance sheet total	€ 357,338 Balance sheet total 2022: € 357,338 First fiscal year in the series	€ 387,098 Balance sheet total 2023: € 387,098 ▲ 8% vs 2022 (€ 357,338) Unchanged	€ 607,524 Balance sheet total 2024: € 607,524 ▲ 57% vs 2023 (€ 387,098) Unchanged	€ 737,696 Balance sheet total 2025: € 737,696 ▲ 21% vs 2024 (€ 607,524) Unchanged	▲ 21%

Key figures of Dr. B. Strubbe, gastro-enterologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. B. Strubbe, gastro-enterologie?

What happened at Dr. B. Strubbe, gastro-enterologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 224,861. Source: NBB ↗
Dec 20, 2021 New establishment in Sint-Martens-Latem. KBO
Dec 20, 2021 Start of the company according to the CBE. KBO

In short

From € 226,973 profit in 2022 to € 224,861 profit in 2025.

Paid € 258,163 in corporate taxes since 2022.

Best year ever: 2022, with € 226,973 profit.

Paid out € 813,800 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. B. Strubbe, gastro-enterologie? We notify you, reason included.

Follow Dr. B. Strubbe, gastro-enterologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Beatrijs Strubbe

Dr. B. Strubbe, gastro-enterologie

Behind Dr. B. Strubbe, gastro-enterologie is Beatrijs Strubbe.

See the full network in the app

Directors

According to the 2025 annual accounts

Beatrijs Strubbe

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Gustaaf De Smetlaan 8

9831 Sint-Martens-Latem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0778.837.249
VAT number: BE 0778.837.249
Registered office: Gustaaf De Smetlaan 8, 9831 Sint-Martens-Latem
Names & denominations: Dr. B. Strubbe, gastro-enterologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 December 2021
Peppol: Active · Active since 26 Nov 2025

View on CBE Public ↗ Annual accounts (NBB) ↗